The Market

Venture Concept

• 600 million people suffer from Depression and/or Anxiety.
• —Only 50% have access to current treatments.
• —Brainfulness device doesn’t need an expensive doctor or hospitalization and can be used by the patient himself, ANY TIME and ANYWHERE, as OFTEN as needed and at a 1 time FIXED cost.
• NO SIDE EFFECTS but IMMEDIATE POSITIVE and ACCUMULATIVE EFFECTS.

Market Opportunity 

• —Antidepressant market (2011) is $11,9 billion and growing 10 to 20 percent each year (GBO Research). 
• —85% of the market is controlled by 5 companies; Wyeth (36%) Eli Lilly (25%) Forest Lab (21%) GSK (11%) Pfizer (5%). 
• —“Depression will displace heart disease as the heaviest disease burden by 2020” (WHO)
• —Our customers are the users of all current treatments and all the millions of patients who do not have treatment.

Competitive Advantages 

• The technology we use is patented and has a proof of concept
• No side-effects what so ever

• Immediate relief

• —Extremely competitive price

• can be used completely anonymous

Risks

• ——Scale and power of competitors
• Selling a device treating depression and anxaiety instead of medication and other existing treatments

—

Comparison with other Treatments

—

—

—Cost Comparison

1000 Anxiety and depressed patients with Brainfulness will cost 1,700,000 USD.

1000 Anxiety and depressed patients currently cost the USA 11.000.000 USD.

The yearly healthcare cost of a person diagnosed with depression in the USA is currently estimated at 22.960 , double from a person without any signs of depression who's healthcare cost are estimated at 11.360-. (source : www.healthline.com)

When talking about anxiety the numbers are even more staggering: most common mental illness in the U.S., affecting 40 million adults in the United States age 18 and older, or 18% of the population. (Source: National Institute of Mental Health in the USA)

Anxiety disorders are highly treatable, yet only about one-third of those suffering receive treatment.

Anxiety disorders cost the U.S. more than 42 billion a year, almost one-third of the country's 148 billion total mental health bill, according to "The Economic Burden of Anxiety Disorders," a study commissioned by ADAA (The Journal of Clinical Psychiatry,60(7), July 1999).

More than 22.84 billion of those costs are associated with the repeated use of health care services; people with anxiety disorders seek relief for symptoms that mimic physical illnesses.

People with an anxiety disorder are three to five times more likely to go to the doctor and six times more likely to be hospitalized for psychiatric disorders than those who do not suffer from anxiety disorders.